Erin Chung1, Eric J Chow2, Naomi C Wilcox2, Roy Burstein3, Elisabeth Brandstetter2,4, Peter D Han4,5, Kairsten Fay6, Brian Pfau4,5, Amanda Adler7, Kirsten Lacombe7, Christina M Lockwood4,8, Timothy M Uyeki9, Jay Shendure4,5,10, Jeffrey S Duchin2,11, Mark J Rieder4,5, Deborah A Nickerson4,5, Michael Boeckh2,6, Michael Famulare3, James P Hughes12, Lea M Starita4,5, Trevor Bedford4,5,6, Janet A Englund7, Helen Y Chu2. 1. Department of Pediatrics, University of Washington, Seattle Children's Hospital, Seattle. 2. Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle. 3. Institute for Disease Modeling, Seattle, Washington. 4. Brotman Baty Institute for Precision Medicine, Seattle, Washington. 5. Department of Genome Sciences, University of Washington, Seattle. 6. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. 7. Seattle Children's Research Institute, Seattle, Washington. 8. Department of Laboratory Medicine and Pathology, University of Washington, Seattle. 9. Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia. 10. Howard Hughes Medical Institute, Seattle, Washington. 11. Public Health-Seattle & King County, Seattle, Washington. 12. Department of Biostatistics, University of Washington, Seattle.
Abstract
Importance: The association between COVID-19 symptoms and SARS-CoV-2 viral levels in children living in the community is not well understood. Objective: To characterize symptoms of pediatric COVID-19 in the community and analyze the association between symptoms and SARS-CoV-2 RNA levels, as approximated by cycle threshold (Ct) values, in children and adults. Design, Setting, and Participants: This cross-sectional study used a respiratory virus surveillance platform in persons of all ages to detect community COVID-19 cases from March 23 to November 9, 2020. A population-based convenience sample of children younger than 18 years and adults in King County, Washington, who enrolled online for home self-collection of upper respiratory samples for SARS-CoV-2 testing were included. Exposures: Detection of SARS-CoV-2 RNA by reverse transcription-polymerase chain reaction (RT-PCR) from participant-collected samples. Main Outcomes and Measures: RT-PCR-confirmed SARS-CoV-2 infection, with Ct values stratified by age and symptoms. Results: Among 555 SARS-CoV-2-positive participants (mean [SD] age, 33.7 [20.1] years; 320 were female [57.7%]), 47 of 123 children (38.2%) were asymptomatic compared with 31 of 432 adults (7.2%). When symptomatic, fewer symptoms were reported in children compared with adults (mean [SD], 1.6 [2.0] vs 4.5 [3.1]). Symptomatic individuals had lower Ct values (which corresponded to higher viral RNA levels) than asymptomatic individuals (adjusted estimate for children, -3.0; 95% CI, -5.5 to -0.6; P = .02; adjusted estimate for adults, -2.9; 95% CI, -5.2 to -0.6; P = .01). The difference in mean Ct values was neither statistically significant between symptomatic children and symptomatic adults (adjusted estimate, -0.7; 95% CI, -2.2 to 0.9; P = .41) nor between asymptomatic children and asymptomatic adults (adjusted estimate, -0.6; 95% CI, -4.0 to 2.8; P = .74). Conclusions and Relevance: In this community-based cross-sectional study, SARS-CoV-2 RNA levels, as determined by Ct values, were significantly higher in symptomatic individuals than in asymptomatic individuals and no significant age-related differences were found. Further research is needed to understand the role of SARS-CoV-2 RNA levels and viral transmission.
Importance: The association between COVID-19 symptoms and SARS-CoV-2 viral levels in children living in the community is not well understood. Objective: To characterize symptoms of pediatric COVID-19 in the community and analyze the association between symptoms and SARS-CoV-2 RNA levels, as approximated by cycle threshold (Ct) values, in children and adults. Design, Setting, and Participants: This cross-sectional study used a respiratory virus surveillance platform in persons of all ages to detect community COVID-19 cases from March 23 to November 9, 2020. A population-based convenience sample of children younger than 18 years and adults in King County, Washington, who enrolled online for home self-collection of upper respiratory samples for SARS-CoV-2 testing were included. Exposures: Detection of SARS-CoV-2 RNA by reverse transcription-polymerase chain reaction (RT-PCR) from participant-collected samples. Main Outcomes and Measures: RT-PCR-confirmed SARS-CoV-2 infection, with Ct values stratified by age and symptoms. Results: Among 555 SARS-CoV-2-positive participants (mean [SD] age, 33.7 [20.1] years; 320 were female [57.7%]), 47 of 123 children (38.2%) were asymptomatic compared with 31 of 432 adults (7.2%). When symptomatic, fewer symptoms were reported in children compared with adults (mean [SD], 1.6 [2.0] vs 4.5 [3.1]). Symptomatic individuals had lower Ct values (which corresponded to higher viral RNA levels) than asymptomatic individuals (adjusted estimate for children, -3.0; 95% CI, -5.5 to -0.6; P = .02; adjusted estimate for adults, -2.9; 95% CI, -5.2 to -0.6; P = .01). The difference in mean Ct values was neither statistically significant between symptomatic children and symptomatic adults (adjusted estimate, -0.7; 95% CI, -2.2 to 0.9; P = .41) nor between asymptomatic children and asymptomatic adults (adjusted estimate, -0.6; 95% CI, -4.0 to 2.8; P = .74). Conclusions and Relevance: In this community-based cross-sectional study, SARS-CoV-2 RNA levels, as determined by Ct values, were significantly higher in symptomatic individuals than in asymptomatic individuals and no significant age-related differences were found. Further research is needed to understand the role of SARS-CoV-2 RNA levels and viral transmission.
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: Ann Intern Med Date: 2007-10-16 Impact factor: 25.391
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Jared Bullard; Kerry Dust; Duane Funk; James E Strong; David Alexander; Lauren Garnett; Carl Boodman; Alexander Bello; Adam Hedley; Zachary Schiffman; Kaylie Doan; Nathalie Bastien; Yan Li; Paul G Van Caeseele; Guillaume Poliquin Journal: Clin Infect Dis Date: 2020-12-17 Impact factor: 9.079
Authors: Taylor Heald-Sargent; William J Muller; Xiaotian Zheng; Jason Rippe; Ami B Patel; Larry K Kociolek Journal: JAMA Pediatr Date: 2020-09-01 Impact factor: 16.193
Authors: Helen Y Chu; Janet A Englund; Lea M Starita; Michael Famulare; Elisabeth Brandstetter; Deborah A Nickerson; Mark J Rieder; Amanda Adler; Kirsten Lacombe; Ashley E Kim; Chelsey Graham; Jennifer Logue; Caitlin R Wolf; Jessica Heimonen; Denise J McCulloch; Peter D Han; Thomas R Sibley; Jover Lee; Misja Ilcisin; Kairsten Fay; Roy Burstein; Beth Martin; Christina M Lockwood; Matthew Thompson; Barry Lutz; Michael Jackson; James P Hughes; Michael Boeckh; Jay Shendure; Trevor Bedford Journal: N Engl J Med Date: 2020-05-01 Impact factor: 91.245
Authors: Ansel Hoang; Kevin Chorath; Axel Moreira; Mary Evans; Finn Burmeister-Morton; Fiona Burmeister; Rija Naqvi; Matthew Petershack; Alvaro Moreira Journal: EClinicalMedicine Date: 2020-06-26
Authors: Jacqueline Dinnes; Pawana Sharma; Sarah Berhane; Susanna S van Wyk; Nicholas Nyaaba; Julie Domen; Melissa Taylor; Jane Cunningham; Clare Davenport; Sabine Dittrich; Devy Emperador; Lotty Hooft; Mariska Mg Leeflang; Matthew Df McInnes; René Spijker; Jan Y Verbakel; Yemisi Takwoingi; Sian Taylor-Phillips; Ann Van den Bruel; Jonathan J Deeks Journal: Cochrane Database Syst Rev Date: 2022-07-22
Authors: Huong Q McLean; Carlos G Grijalva; Kayla E Hanson; Yuwei Zhu; Jessica E Deyoe; Jennifer K Meece; Natasha B Halasa; James D Chappell; Alexandra M Mellis; Carrie Reed; Edward A Belongia; H Keipp Talbot; Melissa A Rolfes Journal: Pediatrics Date: 2022-03-01 Impact factor: 9.703
Authors: Huong Q McLean; Carlos G Grijalva; Kayla E Hanson; Yuwei G Zhu; Jessica E Deyoe; Jennifer K Meece; Natasha B Halasa; James D Chappell; Alexandra Mellis; Carrie Reed; Edward A Belongia; H Keipp Talbot; Melissa A Rolfes Journal: medRxiv Date: 2021-08-20
Authors: Ton That Thanh; Nguyen Thi Thanh Nhan; Nguyen To Anh; Le Thanh Chung; Phan Thi Thuy Duyen; Le Thi Kim Chi; Nguyen Thi Hoai Thu; Pham Thi Hieu; Dinh Van Phuc; Pham Viet Son; Dang Quang Anh; Pham Thi Nam; Nguyen Tri Thuc; Nguyen Thi Hanh; Le Thi Thuy; Le Ly Thuy Tram; Le Kim Thanh; Nguyen Thi Han Ny; Le Nguyen Truc Nhu; Nguyen Van Vinh Chau; Guy Thwaites; Tran Tan Thanh; Le Van Tan Journal: J Infect Date: 2022-01-13 Impact factor: 38.637
Authors: Helen C Stankiewicz Karita; Tracy Q Dong; Christine Johnston; Kathleen M Neuzil; Michael K Paasche-Orlow; Patricia J Kissinger; Anna Bershteyn; Lorna E Thorpe; Meagan Deming; Angelica Kottkamp; Miriam Laufer; Raphael J Landovitz; Alfred Luk; Risa Hoffman; Pavitra Roychoudhury; Craig A Magaret; Alexander L Greninger; Meei-Li Huang; Keith R Jerome; Mark Wener; Connie Celum; Helen Y Chu; Jared M Baeten; Anna Wald; Ruanne V Barnabas; Elizabeth R Brown Journal: JAMA Netw Open Date: 2022-01-04
Authors: T Alex Perkins; Melissa Stephens; Wendy Alvarez Barrios; Sean Cavany; Liz Rulli; Michael E Pfrender Journal: Microbiol Spectr Date: 2022-01-19